Fragment-based drug discovery using NMR spectroscopy.

Fragment-based drug discovery using NMR spectroscopy.
复制标题

DOI:
10.1007/s10858-013-9740-z
复制
发表时间:
2013-06
影响因子:
2.7
通讯作者:
Fesik SW
Fesik SW
中科院分区:
生物学3区
文献类型:
--
作者:
Harner MJ;Frank AO;Fesik SW

文献摘要

参考文献

被引文献

相似文献

在过去的二十年里,核磁共振(NMR)光谱学已经发展成为基于片段的药物发现的有力工具。虽然NMR传统上被用于阐明生物大分子的三维结构和动力学及其相互作用,但它也可以是可靠识别与蛋白质结合的小分子和命中-铅优化的非常有价值的工具。在这里,我们描述了使用NMR光谱作为基于片段的药物发现的方法,以及如何最有效地利用这种方法来发现基于我们的经验的新疗法。
Nuclear magnetic resonance (NMR) spectroscopy has evolved into a powerful tool for fragment-based drug discovery over the last two decades. While NMR has been traditionally used to elucidate the three-dimensional structures and dynamics of biomacromolecules and their interactions, it can also be a very valuable tool for the reliable identification of small molecules that bind to proteins and for hit-to-lead optimization. Here, we describe the use of NMR spectroscopy as a method for fragment-based drug discovery and how to most effectively utilize this approach for discovering novel therapeutics based on our experience.
DOI: 10.1021/jm301448p
发表时间: 2013-01-10
影响因子: 7.3
作者:
Friberg, Anders;Vigil, Dominico;Zhao, Bin;Daniels, R. Nathan;Burke, Jason P.;Garcia-Barrantes, Pedro M.;Camper, DeMarco;Chauder, Brian A.;Lee, Taekyu;Olejniczak, Edward T.;Fesik, Stephen W.
通讯作者: Fesik, Stephen W.
DOI: 10.1021/jm000164q
发表时间: 2000-09-07
影响因子: 7.3
作者:
Hajduk, PJ;Bures, M;Fesik, SW
通讯作者: Fesik, SW
DOI: 10.2174/1386207023329923
发表时间: 2002-12-01
影响因子: 1.8
作者:
Dalvit, C;Flocco, M;Stockman, BJ
通讯作者: Stockman, BJ
DOI: 10.1016/j.ddtec.2004.10.003
发表时间: 2004-12-01
期刊: Drug discovery today. Technologies
影响因子: --
作者:
Fernandez, Cesar;Jahnke, Wolfgang
通讯作者: Jahnke, Wolfgang
DOI: 10.1021/ja039480v
发表时间: 2004-03-03
影响因子: 15
作者:
Hajduk, PJ;Mack, JC;Beutel, BA
通讯作者: Beutel, BA